There is growing evidence implicating dysfunctional glutamatergic neurotransmission and abnormal interactions between the glutamate and dopamine (DA) systems in the pathophysiology of various neuropsychiatric disorders including schizophrenia. The present study evaluated knockout (KO) mice lacking the L-a-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) GluR1 receptor subunit for a range of behaviors considered relevant to certain symptoms of schizophrenia. KO showed locomotor hyperactivity during exposure to open field and in response to a novel object, but normal activity in a familiar home cage. Open field locomotor hyperactivity in KO was effectively normalized to WT levels by treatment with the DA antagonist and neuroleptic haloperidol, while locomotor stimulant effects of the NMDA receptor antagonist MK-801 were absent in KO. Social behaviors during a dyadic conspecific encounter were disorganized in KO. KO showed deficits in prepulse inhibition of the acoustic startle response. In vivo chronoamperometric measurement of extracellular DA clearance in striatum demonstrated retarded clearance in KO. These data demonstrate behavioral abnormalities potentially pertinent to schizophrenia in GluR1 KO, together with evidence of dysregulated DA function. Present findings provide novel insight into the potential role of GluR1, AMPA receptors and glutamate Â DA interactions in the pathophysiology of schizophrenia and other neuropsychiatric conditions.
Introduction
There is growing evidence implicating the glutamate system in the pathophysiology of schizophrenia. [1] [2] [3] [4] [5] A major facet of glutamatergic neurotransmission is action at L-a-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptors: postsynaptic heterooligomeric proteins composed of one or more glutamate receptor GluR1-GluR4 subunits. There is compelling evidence that the GluR1 subunits play a critical role in mediation of synaptic plasticity and cognition 6, 7 impairment of which is increasingly considered to be a cardinal pathophysiological feature of schizophrenia. 1 A more nascent literature suggests that there may be lesser GluR1 gene expression in the hippocampus, striatum and prefrontal cortex of schizophrenics as compared to controls, and reversal of these abnormalities following neuroleptic treatment, [8] [9] [10] [11] leading to interest in AMPA receptors as novel neuroleptic targets. 12, 13 Moreover, the gene encoding GluR1 (GRIA1) lies in a chromosomal region (5q33) associated with schizophrenia [14] [15] [16] and there is preliminary evidence that variation in the GRIA1 gene is associated with the disease. 17 Rodent models provide important tools for elucidating the pathophysiology of psychiatric disease. [18] [19] [20] Various behavioral measures in rodents have been proposed as useful correlates of the symptoms of schizophrenia, including locomotor hyperactivity in response to novelty and stress, sensorimotor gating deficits, abnormal social behaviors, and cognitive impairment. [21] [22] [23] Employing these phenotypic end points, a number of studies have reported 'schizophrenia-related' abnormalities in mice with engineered mutations in various synaptic and downstream signaling components of the glutamate system, including NMDA NR1 receptor, NMDA receptor glycine binding site, mGluR1, mGluR2 and mGluR5 receptors, glycine transporter, calcineurin and Homer1. [24] [25] [26] [27] [28] [29] Previous studies have demonstrated that GluR1 knockout mice (KO) 30 exhibit behavioral abnormalities on tests for cognition, motor function and responses to drugs of abuse. [30] [31] [32] [33] [34] [35] [36] [37] In the present study, we sought to extend these data by assessing these mice for a variety of 'schizophrenia-related' phenotypes. In addition, given the wealth of evidence implicating dysfunction of dopamine (DA) neurotransmission in schizophrenia 2 and the major interaction between the dopamine and glutamate systems, 2, 38 we evaluated regulation of extracellular striatal DA in GluR1 KO in vivo using high-speed chronoamperometry.
Materials and methods
Animals KO were generated as described previously. 30 The mutation was backcrossed into C57BL/6J; analysis of 150 SNP markers at B15-20 megabase intervals across all autosomal chromosomes confirmed B75% congenicity (JRS Allele Typing Services, The Jackson Laboratory, Bar Harbor, ME, USA). With the exception of mice for novel object exploration (conducted at Max-Planck Institute, Heidelberg, Germany), KO, HET and WT were littermates bred from HET parents at The Jackson Laboratory, and housed in same-sex groupings in a temperature-and humidity-controlled vivarium under a 12 h light/dark cycle (lights on 0600 h) at the NIH (behavior) or UTHSC (neurochemistry). Mice were 2-10 months old at the time of testing.
To control for possible phenotypic abnormalities in physical health, and simple sensory and neurological functions, KO were evaluated on a functional observation battery 39 (Supplementary Table 1 ). Testing was conducted during the light phase between 0900 and 1700 h following a 1-hr period of acclimation to test room. Approximately equal number of males and females within each genotype were tested. To reduce the total numbers used, the same mice were tested for (single exposure) open field (OF), prepulse inhibition of startle and home cage activity, another set of the same mice were tested for response to a novel object and another set on the functional observation battery and for social behavior. The number of mice used in each experiment is given in the figure legends. All procedures were performed in accordance with the National Institutes of Health Guide for Care and Use of Laboratory Animals and were approved by the local Animal Care and Use Committee.
Single and repeated OF exposure Mice were placed in a corner of a square (39 Â 39 Â 35 cm) OF 39 with opaque white Plexiglas walls and floor (B95 lx) and allowed to freely explore for 3 h. A separate cohort was tested in the same manner for 30 min once daily for 5 consecutive days. Total distance traveled was quantified using the Ethovision videotracking system (Noldus Information Technology, Leesburg, VA, USA).
Home cage activity
Mice were individually housed in a standard home cage under familiar vivarium conditions for a 48 h acclimation period. 39 Activity was then measured for 24 h using the photocell-based Opto M3 activity monitor (Columbus Instruments, Columbus, OH, USA).
Response to a novel object After a 60-min period of acclimation to an empty OF, a novel object (12 oz Diet Coke can) was placed in the center. Total distance traveled and time spent in the proximity (10 Â 10 cm region) of the object was measured using Ethovision.
Novel object recognition
Mice were placed in a corner of a square OF (60 Â 60 Â 30 cm) with opaque black wooden walls and white floor (B60 lx) for 7 Â 6-min sessions (4-min interval). On session 1 the OF was empty. On sessions 2-6, five inert objects were placed in fixed locations around the OF. On session 7, one object was replaced with a novel object. Relative time spent exploring the novel object vs the average exploration of the familiar objects was measured using a custom-built videotracking system and expressed as a novel vs familiar object exploration ratio.
Effects of dopamine D2-like receptor antagonist, haloperidol, on OF locomotor activity Drug-naive mice were not acclimated to the OF (to facilitate detection of the locomotor depressant effects). Mice were injected intraperitoneally (i.p.) in a volume of 10 ml/kg body weight with 0 or 0.3 mg/kg haloperidol (Sigma, St Louis, MO, USA) and immediately tested in the OF for 30 min. Drug dose was chosen on the basis of previous work 26 and pilot data in our laboratory to produce a submaximal locomotor depressant effect in WT.
Effects of NMDA receptor antagonist, MK-801, on OF locomotor activity After 60 min OF acclimation (to facilitate detection of locomotor stimulant effects), drug-naive mice were injected i.p. in a volume of 10 ml/kg body weight with MK-801 (Sigma) and tested for 60 min. We examined the effects of 0.1-0.3 mg/kg (based on Gainetdinov et al. 40 ) in non-mutant C57BL/6J mice (The Jackson Laboratory) to determine dose-related effects of the drug under our laboratory conditions. On the basis of the data obtained, separate groups of GluR1 KO mice were tested for responses to either a locomotorstimulant (0.3 mg/kg) or a subthreshold (0.1 mg/kg) dose of MK-801.
Social behavior
Social interaction was measured by placing the mouse in a clean empty cage for 60 min acclimation and then introducing an unfamiliar male C57BL/6J stimulus mouse for 10 min. The same stimulus mouse was only used once per day. Mice were observed for anogenital-directed (snout in physical contact with the anogenital region) and non-anogenital-directed (snout in physical contact with any part of the body other than the anogenital region) social investigation of the stimulus mouse using the Hindsight behavioral observation system (Scientific Programming Services, Wokingham, UK).
Prepulse inhibition of acoustic startle PPI was measured using 4 SR-Lab System startle chambers (San Diego Instruments, San Diego, CA, USA). 41 After 5 min acclimation in the clear Plexiglas holding cylinders, mice were presented with startle trials (40-ms 120-dB broadband sound pulse) and prepulse þ startle trials (20-ms noise prepulse sound followed, 100 ms later, by a 40-ms 120-dB broadband sound pulse). Prepulse intensities were 3, 6 and 12 dB above background (65 dB broadband background noise, present throughout session). Each trial type was presented 10 Â with a variable (12-30 s) interval. Five pulse-alone trials began and ended the session (not included in the analysis). Basal activity was measured during no-stimulus trials. Whole-body startle responses were measured via vibrations transduced into analog signals by a piezoelectric unit attached to the platform on which the cylinders rested. Startle amplitude was measured every 1 ms over a 65 ms period beginning at the onset of the startle stimulus. Average startle amplitude over the sampling period was taken as the dependent variable. PPI at each prepulse intensity was calculated as 100À[(startle response for prepulse þ startle trials/ startle response for startle-alone trials) Â 100].
In vivo high-speed chronoamperometric measurement of extracellular fluid striatal dopamine clearance DA clearance in striatum was measured in (chloralose and urethane) anesthetized mice via high-speed chronoamperometry using the FAST-12 system (Quanteon, Nicholasville, KY, USA) essentially as described previously. 42 This procedure measures clearance of DA from the extracellular environment with little or no contribution from released DA. 43 Briefly, oxidation potentials consisting of 100 ms pulses of þ 0.55 V were applied to a carbon fiber electrode. Each pulse was separated by a 900 ms interval during which the resting potential was maintained at 0.0 V. Voltage at the active electrode was applied with respect to a Ag/AgCl reference electrode positioned in the extracellular fluid of the ipsilateral superficial cortex. The oxidation and reduction currents were digitally integrated during the last 80 ms of each 100 ms voltage pulse. Carbon fiber electrodes were coated with Nafion (5% solution; Aldrich Chemical Co, Milwaukee, WI, USA) to prevent interference from anionic substances in extracellular fluid and calibrated to DA in vitro. The detection limit for the measurement of DA averaged 3178 nM (n = 61 electrodes).
The electrode-micropipette recording assembly was lowered into the striatum (AP þ 1.1, ML þ 1.2 to À1.5, DV À2.0 to À2.7) according to plate 22 of Paxinos and Franklin. 44 To determine maximal rates of DA clearance, barrels were filled with DA (200 mM, Sigma) dissolved in 0.1 M phosphate-buffered saline and 100 mM ascorbic acid added as an antioxidant (pH 7.3-7.4). DA volumes were manipulated and pressure ejected to deliver 5, 10, 20, 50 or 100 pmol amounts of DA at 5 min intervals, in an order randomized across mice and genotypes. Delivery procedures and pmol DA amounts were selected to allow determination of (up to maximal) velocity of DA clearance and estimate the apparent affinity of the dopamine transporter (DAT) for DA across genotypes. 45 Three dependent measures were obtained: (1) clearance velocity (V), defined as the slope of the most linear portion of the decay curve (that is, 20-60% maximal signal amplitude), (2) maximal clearance velocity (V max ), (3) apparent transporter affinity (K T ) (corrected for volume fraction, a = 0.2). V max and K T were determined by fitting a rectangular hyperbola to a plot of V vs DA concentration (mM) or amount (pmol) using GraphPad Prism 4.0 (Hearne Scientific Software, Chicago, IL, USA).
To verify that any observed genotype differences in DA clearance was dissociated from potential differences in DA release, we quantified DA release evoked by amphetamine. On completion of baseline measurements of DA clearance, the micropipette recording assembly was moved to the same stereotaxic coordinates in the contralateral striatum. Amphetamine (50 pmol, 400 mM barrel concentration) was pressure-ejected and subsequent release of endogenous DA measured. The hemisphere used for basal and amphetamine-evoked measurements was counterbalanced across mice.
On completion of chronoamperometry, an electrolytic lesion was made to mark the placement of the electrode tip and mice were killed by cervical dislocation and decapitation and brains rapidly frozen on dry ice and stored at À801C. Brains were thawed to À151C and cut into 20 mM sections for histological verification of electrode localization and, in a subset of mice, autoradiographic quantification of DAT expression. DAT was measured using 3 nM 46 Briefly, sections were preincubated in a buffer consisting of 9.5 mM Na 2 H 2 PO 4 Á H 2 O, 40.5 mM Na 2 H 2 PO 4 , 50mM NaCl followed by incubation in the same buffer with 0.32 mM sucrose. Non specific binding was defined using 1 mM GBR 12783 (Tocris, Ellisville, MI, USA). Sections were washed, dried and opposed to Kodak BioMax MR film along with calibrated [ 3 H] standards (ARC, St Louis, MO, USA) for 6 weeks to generate autoradiograms. Optical densities of striatal images were converted to fmol/mg protein using NIH-Image software.
Statistics
There was no genotype Â sex interaction for any measure and data were collapsed across sex. The effect of genotype was analyzed using one-factor analysis of variance (ANOVA). Effects of genotype Â drug, genotype Â time/day, and genotype Â DA concentration were analyzed using two-factor ANOVA, with repeated measures for drug/time/day/DA concentration, followed by Newman-Keuls post hoc analysis where appropriate. Novel object exploration was compared to chance for each genotype using the Kruskal-Wallis test. Statistical significance was set at P < 0.05.
Results
Locomotor hyperactivity in OF, not home cage KO showed significantly more locomotor activity than WT during a single exposure to the OF (F(2,19) = 10.03, P < 0.01; Figure 1a ). Locomotor activity in KO showed within-session habituation, but did not fall to WT levels even after 5 consecutive daily OF exposures (genotype Â time interaction, F(58,841) = 2.29, P < 0.01; Figure 1b) . By contrast, locomotor activity in the home cage was no different between genotypes (NS; Figure 1c ).
Exaggerated locomotor responses to a novel object, normal novel object recognition KO displayed greater locomotor activity than WT during acclimation to the OF. When a novel object was placed in the center of the OF all genotypes showed an increase in locomotor activity; however KO showed a significantly greater increase than WT (time Â genotype interaction, F(178,3649) = 3.49, P < 0.01; Figure 2a ). KO also spent significantly more time in the proximity of the novel object than WT (time Â genotype interaction, F(178,3649) = 15.87, P < 0.01; Figures 2b and c) . The exaggerated KO response to the novel object was also demonstrated by comparing locomotor activity (F(2,41) = 14.42, P < 0.01; Figure 2a , Supplementary Figure 1A) and time spent near the object (F(2,41) = 35.57, P < 0.01; Figure 2b , Supplementary Figure 1B) during the 10 min before vs 10 min after object exposure. KO showed normal novel object recognition. Both WT and KO exhibited increased exploration of a novel object relative to four familiar objects (novel vs familiar object exploration ratio: WT = 3.871.8, H = 14.60, P < 0.01 vs chance; KO = 7.372.7, H = 12.06, P < 0.01 vs chance).
Reversal of locomotor hyperactivity by haloperidol
Treatment with haloperidol reduced OF locomotor activity in all genotypes; however the decrease was greater in KO (dose Â genotype interaction, F(2,42) = 8.09, P < 0.01; Figure 3 ).
Attenuated locomotor stimulant effects of MK-801
Drug groups of C57BL/6J mice did not differ in activity before drug treatment, although all showed significant habituation (effect of time, F(11,264) = 7.96, P < 0.01). Treatment with ( þ )-5-methyl-10,11-dihydro-SH-dibenzo[a,d]cyclohepten-5,10-imine maleate (MK-801, dizocilpine) produced a significant increase in OF locomotor activity at a dose of 0.2 and 0.3 but not 0.1 mg/kg (dose Â time interaction: F(30,240) = 11.59, P < 0.01; Figure 4a ).
Before drug treatment KO were significantly more active than WT, and all genotypes showed significant habituation (genotype Â time interaction: F(22,308) = 6.27, P < 0.01). Following treatment with a dose of MK-801 that was active in C57BL/6J (0.3 mg/kg), there was a significant increase in locomotor activity in WT and HET but not KO (genotype Â time interaction: F(20,280) = 2.95, P < 0.01; Figure 4b) .
In a separate cohort, KO were again significantly more active than WT before drug treatment, and all genotypes showed significant habituation (genotype Â time interaction: F(22,209) = 1.87, P < 0.05). Following treatment with a subthreshold dose of MK-801 (0.1 mg/kg), none of the genotypes showed a change in activity and KO remained more active than WT (main effect of genotype: F(2,19) = 16.14, P < 0.01; effect of time, ns; genotype Â time, NS) and there was no evidence of drug-induced changes in activity in any genotype; Figure 4c ).
Abnormal social behavior
Overall social investigation did not differ between genotypes (Figure 5a ). However KO engaged in shorter social interactions than WT (F(2,41) = 3.41, P < 0.05; Figure 5b ). While genotypes did not differ in the number of social investigations directed at the anogenital region (Figure 5c ), KO engaged in more non-anogenital investigations than WT (F(2,41) = 9.01, P < 0.01; Figure 5d ). Aggression was negligible, with only 2 mice (HET) out of 44 exhibiting aggression. (There were no effects of sex or sex Â genotype interactions for any measure.)
Impaired prepulse inhibition PPI increased monotonically with increased prepulse intensities in all genotypes (F(2,84) = 42.62, P < 0.01).
Irrespective of prepulse intensity KO showed significantly lower PPI scores than WT (genotype effect, F(2,42) = 6.32, P < 0.01; Figure 6a ). There was no genotype effect on baseline movement (not shown) or startle amplitude (Figure 6b ).
Reduced DA clearance and normal DAT expression in striatum All genotypes showed increased rates of striatal DA clearance with increasing DA concentrations. Clear- 
Discussion
Confirming previous data, 35, 47 GluR1 KO exhibited marked locomotor hyperactivity during exposure to an OF. Genotype differences were still evident after five daily 30 min test exposure. Specifically, while WT and HET had habituated to floor levels of activity by the third exposure, KOs showed clear withinsession habituation but 'spontaneously recovered' their hyperactivity at the beginning of each exposure. In contrast to this marked difference in activity in the OF, activity levels in GluR1 KO mice were no different from WT in the familiar, low-provocation environment of the home cage. Taken together, these data demonstrate that GluR1 KO mice exhibit a habituation-resistant behavioral hyperexcitability in response to even modestly provocative environmental stimulation.
This conclusion was reinforced by the abnormal response of GluR1 KO to a novel object and a social stimulus. When confronted with a novel object in the OF, all genotypes showed an increase in activity; however the locomotor response in KO was stronger, longer lasting and manifest as intense exploration of the object. This behavior in the KOs was not associated with a general failure to form a lasting representation of a novel object, as demonstrated by intact novel object recognition performance. Interestingly in the context of these data, symptoms of schizophrenia are also provoked by stress and the glutamate system is profoundly sensitive to both novelty and stress. 48 Measuring social interactions with an unfamiliar conspecific, KO did not engage in more or less social interaction overall. However, bouts of social investigation were of shorter duration in KO than WT, and the KO mice engaged in more bouts of investigation directed away from the anogenital region of the stimulus mouse. An earlier study found that KO fail to show the normal increase in conspecific aggression that occurs in mice following social isolation. 34 Taken together, these data suggest that these mice do not respond normally to social signals and/or fail to appropriately organize behavior in social contexts.
Completing the current baseline behavioral phenotypic profiling of GluR1 KO was the finding that these mice showed significant impairment of PPI. PPI provides a well-validated, translatable model of sensorimotor gating deficits found in schizophrenia and certain neuropsychiatric conditions such as bipolar disorder and attention deficit hyperactivity disorder (ADHD). 49 There were no concomitant changes in acoustic startle amplitude, excluding the possibility of confounding hearing deficits in KO. Moreover, an assessment of various physical parameters and simple measures of neurological functions found the KO mice to be grossly normal. It should also be noted that while GluR1 KO were not fully C57BL/ 6J congenic, it is unlikely that flanking genes extant from the embryonic donor strain (129Sv) account for impaired PPI or other behavioral abnormalities observed, as 129 strains generally exhibit good PPI, as well as locomotor hypoactivity relative to C57BL/6J under conditions in which GluR1 KOs were hyperactive. 41, 50 Thus, the current data provide a profile of a range of behavioral abnormalities in KO that can be considered pertinent to certain symptoms of schizophrenia. As such, these data build upon an elegant series of studies demonstrating selective performance deficits on tests for working memory and cognitive flexibility, behaviors that are also impaired in schizophrenia. [30] [31] [32] [33] Pharmacological blockade of NMDA receptor function with non-selective NMDA antagonist such as phencyclidine and ketamine can induce temporary psychosis in normal human subjects and provoke symptoms in schizophrenics. 51 GluR1 KO have been found to exhibit a loss of NMDA receptor-mediated long-term potentiation, but normal NMDA-receptorinduced Ca 2 þ influx and NR1 expression, in CA1 hippocampal neurons. 30 The present findings extend these data by showing that treatment with the noncompetitive NMDA receptor antagonist MK-801 (dizocilpine) in WT and HET mimicked the hyperactivity seen in KO, while the KO mice showed no clear response to the same dose. The absence of a locomotor-stimulant response to MK-801 in the KO could be caused by either decreased or increased sensitivity to the drug's effects, as the latter could produce locomotor stereotypies that 'compete out' increased locomotor ambulation. Resolving this issue, all genotypes failed to show a locomotor response to a subthreshold dose of MK-801, demonstrating a loss of sensitivity to this drug in the KO across a range of doses. Decreased rather increased sensitivity to MK-801 in GluR1 KO provides an interesting contrast with the aforementioned psychomimetic effects of NMDA receptor antagonism in humans. One potential explanation is that this reflects an important mechanistic role for GluR1 in a downstream intracellular signaling pathway mediating the locomotor-stimulant effects of MK-801. However, this pathway has not been fully elucidated 52 and further studies will serve to delineate fully the nature of altered NMDA receptor function in GluR1 KO.
There is a long-standing model of DA dysfunction in schizophrenia and growing evidence of major functional inter-relationship between DA and glutamate underlying the pathophysiology of schizophrenia. 2, 38 In non-mutant mice, DA receptor stimulation produces locomotor hyperactivity and PPI deficits, while schizophrenia-related disturbances seen in mice with mutations in the DA system have been linked to glutamatergic dysfunction. 53 Of particular interest is the finding that constitutive KO or partial knockdown of the DAT causes OF (but not home cage) hyperactivity, a resistance to habituation with repeated OF exposure and increased novel object exploration that is similar in many respects to the currently reported phenotype of GluR1 KO. 40, 54 By clearing DA from the extracellular space, DAT plays an essential role in modulating the magnitude and duration of DA's actions. 55 The present data demonstrate significantly retarded clearance of extracellular DA in the striatum of KO, as measured by in vivo high-speed chronoamperometry. This finding raises the question of whether disturbances in DAT function might contribute to the behavior abnormalities in the GluR1 KO. However, impaired DA clearance in GluR1 KO was not associated with reduced apparent transporter affinity or with lesser DAT expression in striatal tissue. Amphetamine-evoked DA release was also normal in KO. In addition, earlier work has shown that tissue levels of DA and its metabolites are not grossly aberrant in KO. 34 Thus, loss of DA clearance appears to result from an alteration in DA clearance capacity, possibly resulting from changes in DAT functionality and/or trafficking, rather than an alteration in DA release, DAT availability or a more general change in the DA synthesis or availability. Loss of DA clearance in KO and the predicted corollary increase in the magnitude and duration of extracellular levels of DA in striatum provides one plausible mechanism driving the abnormal GluR1 KO behavioral responses to conditions in which the DA system is activated, such as novelty, stress and high cognitive demand. This is supported by the observation that treatment with the DA D2-like receptor antagonist and neuroleptic agent, haloperidol, effectively reversed locomotor hyperactivity in KO to levels seen in vehicle-treated WT.
In summary, the present study demonstrated that constitutive loss of the AMPA GluR1 subunit produces a range of behavioral abnormalities believed to model certain symptomatic features of neuropsychiatric disease states including ADHD, bipolar disorder and schizophrenia. The precise neural basis of these phenotypic abnormalities remains to be fully elucidated. The fact that loss of GluR1 also causes marked deficits in synaptic plasticity 6, 7, 30 is intriguing in view of the hypothesis that impaired synaptic plasticity is a central feature of the pathophysiology of schizophrenia. 1 The finding that GluR1 KO exhibited impaired striatal DA clearance is also significant given evidence of abnormal glutamate-DA interactions in schizophrenia. 2, 38 Further understanding of the neural, molecular and behavioral profile of GluR1 KO could ultimately have implications for understanding the etiology and treatment of schizophrenia.
